Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Photonic Integrated Circuits Benefit Greatly From AI Data Center Demand, but Other Applications Are Now Emerging, Says IDTechEx

Published

on

photonic-integrated-circuits-benefit-greatly-from-ai-data-center-demand,-but-other-applications-are-now-emerging,-says-idtechex

BOSTON, May 7, 2024 /PRNewswire/ — The Silicon Photonics and PICs market is experiencing robust growth, driven by the surge in AI and datacom transceiver demand. Key players in the industry, such as Intel, Coherent, and Infinera, are actively using PICs within their transceivers.

What are the benefits and challenges for Silicon Photonics and Photonic Integrated Circuits?
Photonic Integrated Circuits (PICs) are tiny optical systems made of materials such as Silica (Glass), Silicon, or Indium Phosphide. PICs enable everything from complex optical designs that allow billions of bits of information to be sent and received in a package the size of a candy bar to artificial noses that can detect different compounds and molecules in the air around them.
By leveraging the billions of dollars in investment in the CMOS chips, PICs can unlock new processing scaling potential beyond Moore’s law. However, there are still significant challenges for the PIC market, such as material limitations, integration complexity, and cost management. Large demand volumes are required to offset the initial cost of designing and manufacturing PICs, and production lead times can take months. The brand new IDTechEx report on the topic, ‘Silicon Photonics and Photonic Integrated Circuits 2024-2034: Market, Technologies, and Forecasts’, thoroughly investigates the PIC market and has identified Photonic Transceivers for AI as an emerging segment that is soon to be the largest source of demand for PICs.
What are the PIC materials of the future?
There is a wide variety of future PIC materials. Most of the current market uses Silicon and Silica-based PICs for light propagation; however, as an indirect semiconductor, Silicon is not an efficient light source or photodetector. Therefore, Silicon is usually combined with III-V materials for light sources and photodetection. Silicon’s market dominance is set to continue; however, Thin Film Lithium Niobate (TFLN), with its moderate Pockels effect and low material loss, is emerging as a strong contender for applications that require high-performance modulation, such as quantum systems or potentially high-performance transceivers in the future. Monolithic Indium Phosphide (InP) continues to be a major player due to its ability to detect and emit light. Additionally, innovative materials like Barium Titanite (BTO) and rare-earth metals are being explored for their potential in quantum computing and other cutting-edge applications.
How AI is changing the demand for Silicon Photonics and PICs
The rise of Artificial Intelligence (AI) has spurred an unprecedented demand for high-performance transceivers capable of supporting the massive data rates required by AI accelerators and data centers. Silicon Photonics and PICs are at the forefront of this revolution, with their ability to transmit data at speeds of 1.6Tbps and beyond. As shown by Nvidia’s latest Blackwell CPUs, which, according to IDTechEx’s research, require approximately two 800G transceivers per GPU, the need for efficient, high-bandwidth communication is becoming more critical for AI, positioning Silicon Photonics and PICs as essential components in the AI-driven future. The biggest driver of the development of PIC transceivers is AI, as higher-performance AI accelerators will require higher-performance transceivers, with 3.2Tbps transceivers expected to arrive by 2026.
What are the future applications?
Other applications for Silicon Photonics and PICs vary – from high-bandwidth chip-to-chip interconnects to advanced packaging and co-packaged optics. These technologies are paving the way for next-generation computing.
Photonic Engines and Accelerators: Using certain photonic components, such as Mach-Zehnder Interferometers, and controlling these components through electro-optical interconnects, high-performance processors and programmable PIC devices can be designed and manufactured, unlocking higher performance than what is possible with electronic accelerators alone.
PIC-based Sensors: Certain PIC materials, such as Silicon Nitride, can used for a range of different sensors, from gas sensors to ‘artificial noses’. The healthcare sensor industry may be able to take advantage of the miniaturization of optical components into PIC devices, which could see applications in Point-of-Care diagnostics or Wearables.
PIC-based FMCW LiDAR has the potential to transform the automotive and agricultural industries with applications in drones and autonomous vehicles.
Quantum Systems: Companies investing in Trapped Ion and Photon-based Quantum Computing are looking to PICs for more stable and scalable quantum systems. PICs are used in photonic quantum systems to achieve the precise control of photons necessary for quantum computation.
The market for Silicon Photonics and PICs is experiencing robust growth, driven by the surge in AI and datacom transceiver demand. Key players in the industry, such as Intel/Jabil, Coherent, and Infinera, are actively using PICs within their transceivers. Innolight, a China-based transceiver company, hit 1.6Tbps of transfer speed in their latest transceivers in late 2023, which are due to start shipping for data-center applications in 2024. Coherent, which has its own InP wafer fab facilities, is also developing higher-performance transceivers for 1.6T+ applications. Intel Silicon Photonics, which is potentially going to be acquired by manufacturing firm Jabil, sold ~1.7 million PICs in 2023, according to IDTechEx’s analysis, and is continuing to develop datacom and telecom transceivers.  IDTechEx forecasts that PIC technology will continue dominating the high-performance transceiver market, further solidifying its position as a critical component in the modern technological landscape.
Key aspects of the IDTechEx report, ‘Silicon Photonics and Photonic Integrated Circuits 2024-2034: Market, Technologies, and Forecasts’, include:
Key Player Analysis for the High-Performance PIC-based Transceiver MarketA breakdown of Co-Packaged Optics and its key conceptsAnalysis of Photonic Integrated Circuits for Quantum SystemsBenchmarks and comparisons of photonic materials, with an industry breakdown by material. It also includes an insight into emerging materials such as Thin-Film Lithium Niobate (TFLN) and Barium Titanite (BTO).Photonic Integrated Circuit Fundamentals and Key Concepts, including important components and underlying principles.An analysis of how AI is changing demand for PIC-based transceivers, with a look at how Nvidia’s recommended server architecture requires large numbers of transceivers.An overview of PIC manufacturing techniques.A look into future applications of PICs such as interconnects, LiDAR, biosensors, and gas sensors.To find out more about this report, including downloadable sample pages, please visit www.IDTechEx.com/SemiPIC.
Upcoming free-to-attend Webinar
Photonic Integrated Circuits: Materials, Forecasts, and How AI Accelerator Demand Is Affecting the PIC Market
James Falkiner, Technology Analyst at IDTechEx and author of this article, will be presenting a free-to-attend webinar on the topic on Thursday 30 May 2024 – Photonic Integrated Circuits: Materials, Forecasts, and How AI Accelerator Demand Is Affecting the PIC Market.
This webinar will include:
What is a photonic integrated circuit?What are current and future applications for PICs?An insight into IDTechEx’s Total PIC Market ForecastsHow AI accelerator demand is affecting the PIC Transceivers marketThe roadmap for the future of Datacom TransceiversPIC Material Benchmarks and ForecastsPlease click here to check timings and register for your specific time zone.
If you are unable to make the date, please register anyway to receive the links to the on-demand recording (available for a limited time) and webinar slides as soon as they are available.
About IDTechEx:
IDTechEx provides trusted independent research on emerging technologies and their markets. Since 1999, we have been helping our clients to understand new technologies, their supply chains, market requirements, opportunities and forecasts. For more information, contact [email protected] or visit www.IDTechEx.com.
Image download:
https://www.dropbox.com/scl/fo/pf7po53noehr685zsz2zh/APpohA52-QCT0fpKlvMWJBA?rlkey=vvdqces2k9ruabal750wlzoa9&st=5d0bauyt&dl=0
Media Contact:
Lucy RogersSales and Marketing [email protected] +44(0)1223 812300
Social Media Links:
Twitter: www.twitter.com/IDTechExLinkedIn: www.linkedin.com/company/IDTechEx
Photo: https://mma.prnewswire.com/media/2406553/IDTechEx_PIC_Market_CAGR_Infographic.jpgLogo: https://mma.prnewswire.com/media/2338688/4691940/IDTechEx_logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/photonic-integrated-circuits-benefit-greatly-from-ai-data-center-demand-but-other-applications-are-now-emerging-says-idtechex-302138369.html

Continue Reading
Advertisement
Stake.com

Artificial Intelligence

Optellum showcases AI for precision lung cancer treatment at ASCO 2024

Published

on

optellum-showcases-ai-for-precision-lung-cancer-treatment-at-asco-2024

OXFORD, United Kingdom, May 30, 2024 /PRNewswire/ — Optellum, a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has launched its multimodal therapy AI guidance platform for life science research. The novel AI software and scientific results, showing potential to optimize curative lung cancer treatment, will be showcased for the first time at the 2024 ASCO Annual Meeting in Chicago (31 May—4 June).

Lung cancer often shows no symptoms until it reaches an advanced stage, leaving patients with limited treatment options and less favorable outcomes. However, by continuous automated analysis of the 90 million CT scans US patients receive yearly, it may be possible to create an “early detection system”. Optellum Virtual Nodule Clinic, the first FDA-cleared decision support for early-stage lung cancer, integrates a Patient Discovery AI based on Natural Language Processing with a clinically validated Lung Cancer Prediction (LCP) score based on imaging AI/Radiomics. The combination assists clinicians in identifying at-risk patients across health systems and prioritizing them for follow-up interventions.
Early diagnosis offers patients curative treatment options. Unfortunately, some 30% to 60% of Stage I-II NSCLC patients will experience recurrence after surgery. Accurate prognosis of recurrence risk could enable thoracic oncology teams to optimize treatment early, for example, to tailor the extent of surgical resection and ensure neo-adjuvant and peri-operative treatments are offered to those at risk. To drug developers, it may enable risk-stratifying populations to increase treatment rates, expand indications to earlier stages, and predict treatment response.
Optellum will showcase their precision lung cancer care AI solutions at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting. In the ASCO scientific program (Poster Session, 3rd June, 1:30 pm), Optellum’s clinical partners will present results of AI-guided recurrence prognosis in Stage I-III NSCLC from multi-modal pre-surgical data (Abstract #8066 1) showing significantly increased sensitivity for recurrence compared to staging. The Optellum AI solutions will also be demoed at the CancerLinQ booth (#14013) and ConcertAI booth (#12045).
Christine D. Berg, M.D., the co-principal investigator of the National Lung Screening Trial (NLST) at the National Cancer Institute, which paved the way for lung cancer screening implementation, commented: “The accurate determination of prognosis drives treatment decisions in oncology. Radiomic tools combined with demographics, as shown by Optellum, can be an effective non-invasive technology to optimize decision making early in the patient’s journey, which may help to improve outcomes.”
“Our multi-modal AI platform aims to become the ‘operating system’ that guides precision lung cancer care across the patient journey, from early identification to predicting response and monitoring,” said Václav Potěšil, PhD, Founder & Chief Business Officer at Optellum. “Neo-adjuvant therapies are real game changers. Together with our medtech and biopharma partners, we leverage the power of AI to help democratize access to life-saving early diagnosis and precision treatment for every patient who can benefit.”
Learn more here.
About OptellumOptellum is a commercial-stage lung health company providing artificial intelligence decision-support software that assists physicians in early diagnosis and optimal treatment for their patients. The company was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage when the probability of better health outcomes is highest. The Oxford-based medtech company has been the first to achieve FDA 510(k) clearance and reimbursability for US Medicare patients under CMS New Technology APC for the application of AI decision-support software in lung cancer diagnosis. It has since announced strategic partnerships with industry leaders, including GE Healthcare, Johnson & Johnson, and many other top biopharma and medtech companies, while Virtual Nodule Clinic has been implemented in healthcare systems across the USA and Europe. Optellum has headquarters at the Oxford Centre for Innovation in Oxford, UK, and a US office at the Texas Medical Center. For more information, visit optellum.com or follow us on LinkedIn.
Media Contact
Optellum Communications | [email protected]
1 Pre- and post-operative lung cancer recurrence prediction following curative surgery: A retrospective study using European radiomics and clinical data. Ann Valter, Tanel Kordemets, Aydan Gasimova, Noah Waterfield Price, Lutz Freitag, Anil Vachani, David Paul Carbone, Kersti Oselin, https://meetings.asco.org/abstracts-presentations/239181
Logo – https://mma.prnewswire.com/media/1596737/Optellum_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/optellum-showcases-ai-for-precision-lung-cancer-treatment-at-asco-2024-302159353.html

Continue Reading

Artificial Intelligence

Element Biosciences to Showcase Sequencing Innovations at the European Human Genetics Conference

Published

on

element-biosciences-to-showcase-sequencing-innovations-at-the-european-human-genetics-conference

Customers laud the positive impact of AVITI on advancing their scientific research
SAN DIEGO, May 30, 2024 /PRNewswire/ — Element Biosciences, Inc., developer of pioneering technologies to empower science, will showcase the rapidly growing use of its AVITI™ System sequencer across the European scientific community at the European Human Genetics Conference 2024 in Berlin, Germany, on June 1.  

During ESHG 2024, which runs from June 1-4, Element Biosciences’ Chief Technology Officer and Co-Founder Michael Previte will share the latest details on the AVITI24™, the first platform to combine state-of-the-art sequencing and multiomic cell analysis in one integrated biology tool.  The AVITI24 enables the simultaneous measurement of multiple analytes, including DNA, RNA, proteins, phosphorylated proteins, and morphology, in up to one million cells per flow cell.
“At ESHG, we’re excited to show the transformative power of AVITI and highlight how we’re advancing our mission to increase access to high-quality, affordable tools for complex biological research through AVITI24,” said Previte.
The AVITI System is expanding access to faster, more efficient and innovative sequencing for European scientific labs, with Element’s technologies now being used by researchers in most countries in Europe. With its AVITI24 open for preorders, Element also announced that existing customers are prebooking ahead of shipment, including the National Genomics Infrastructure (NGI) at SciLifeLab, a world-leading Swedish national center for large-scale research and one of the largest molecular biology research infrastructures in Europe.
“As part of the National Genomics Infrastructure, we’re committed to staying at the forefront of technology,” said Robert Månsson Welinder, Head of Strategic Relations at NGI. “Element’s AVITI24 will help us push this frontier and allow our scientific community to pursue new and exciting science.”
Leading European scientists emphasized the positive impact the AVITI has had on advancing their scientific research. Igor Fijalkowski, researcher at the Center for Medical Genetics at Ghent University in Belgium, noted the ease of adoption and flexibility of the platform saying “Over the last year or so we performed more than 100 runs of AVITI sequencing and overall, across multiple applications, the sequencing quality has been excellent. The transition was frictionless, so we are very happy with the way the sequencer has been performing.”
Several other researchers noted the cost-effectiveness, high quality, and flexibility of the AVITI platform. “Since the installation of our AVITI we have been blown away by its flexibility and quality outputs,” said Megan Hamilton, Genomics Facility Manager at the Babraham Institute in Cambridge, United Kingdom. Petri Auvinen, Research Director at the Institute of Biotechnology, University of Helsinki, Finland, said “AVITI seems to be the most efficient and most legitimate system to run a new chemistry for sequencing.”
Others called out the unique features of the AVITI not available on other platforms. “The cost-effectiveness of AVITI adds to its high sequencing quality of Q40-50, which makes it an important device in the future of cancer research,” said Romain Boidot, molecular biologist at the Georges-François Leclerc Center, France. Also in France, Charles Poncet, lab manager at INRAE, said “We chose AVITI for its combination of performance, price of the instrument and reagents, flexibility, and applications. We also had the chance to test AVITI with our wheat samples and the results were excellent, especially for an organism with such complex genetics.”
Two years after launching AVITI, the sequencer that provides the highest quality sequencing on a benchtop, Element has continued to innovate on its modular platform. It has introduced faster run times, expanded kit offerings, the Elembio Cloud software platform, and industry-leading affordability, while maintaining unprecedented accuracy.
About Element Biosciences, Inc.
Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook.
Media Contact:Kristi HeimElement [email protected]
Logo – https://mma.prnewswire.com/media/1889504/Element_Biosciences_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/element-biosciences-to-showcase-sequencing-innovations-at-the-european-human-genetics-conference-302159209.html

Continue Reading

Artificial Intelligence

St. Pölten UAS: Networking Meeting of the Higher Education Area

Published

on

st.-polten-uas:-networking-meeting-of-the-higher-education-area

St. Pölten UAS Hosts 33rd EURASHE Annual Conference
Every year, the European Association of Institutions in Higher Education (EURASHE) brings together representatives of the higher education sector in order to discuss and design a common path in important matters for the present and future of education. This year’s meeting was held at the St. Pölten University of Applied Sciences. The focus of the event was on transnational collaborations between higher education institutions and on cooperation with the business world and society. More than 200 experts from all over Europe, Africa, Asia, and the Middle East took part.
ST. PÖLTEN, Austria, May 30, 2024 /PRNewswire/ — EURASHE, the European Association of Institutions in Higher Education, features approximately 600 universities, universities of applied sciences, university colleges, and similar institutions that conduct primarily professional higher education and applied research.

 
Important Voice in the European Higher Education Area”In order to come up with solutions to the diverse challenges of our times, it is necessary for us to integrate the knowledge and experiences of various fields and to further develop our creativity. In most cases, individual higher education institutions can generate only little impact unless they pool their forces. Therefore, international partnerships and university alliances are decisive for future-oriented development”, emphasises St. Pölten UAS CEO Hannes Raffaseder who is the current President of EURASHE. St. Pölten UAS is also the coordinator of the European University Alliance E³UDRES².
„Regarding higher education institutions it’s important that we have a diversity of voices in Europe and EURASHE is a very important voice for the universities of applied sciences. They bring in a different perspective. Typically they are very rooted in the local or regional context. They are close to the labour market and they are very innovative. So we need EURASHE to bring in their perspective and come up with new ideas on how we can make transnational cooperation work better at European level”, says Sophia Eriksson Watershoot, Director for Youth, Education and  Erasmus+ from the European Commission.
“I am happy to have our conference here in St. Pölten. The conference is different each year, and that is what makes EURASHE conferences so interesting. Here at this new campus, people get a feel of how fast changing this sector is. And we had a great diversity of people at the conference this year including guests from all around the world like North America, Asia, and the Middle East”, says John Edwards, Secretary General of EURASHE.
33rd EURASHE Annual Conferencehttps://www.eurashe.eu/events/annual-conference-2024https://www.eurashe.eu
Contact:Mark [email protected]+43 2742 313 228 ext. 269
Logo – https://mma.prnewswire.com/media/1735639/St_Polten_University_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/st-polten-uas-networking-meeting-of-the-higher-education-area-302159314.html

Continue Reading

Trending